Chair: Prof. Dr. Bassem El Menshawi (EGYPT)
Co-Chair: Prof. Dr. Omar El-Ahmady (EGYPT)
February 7, 2012
8:00-8:30 Registration/Sign-In
8:30-9:15 Controlled Release Inhalation Therapy
Dr. Rania Salama (AUSTRALIA, EGYPT)
9:15-10:00 Diagnosis and monitoring of infectious diseases
Dr. Graham Timmins (USA)
10:00-10:30 Coffee Break
10:30-11:15 Isotope-Enhanced Pharmaceuticals to Improve Efficacy and
Deter Counterfeiting
Dr. Graham Timmins (USA)
11:15-12:00 Applications of Solid Lipid Nanoparticles in Cancer Therapy
Dr. Alaa Eldeen Yassin (KSA)
12:00-1:00 Lunch
1:00-1:45 Red Blood Cells as Novel Drug Delivery Systems
Prof. Dr. Fars Alanazi (KSA)
1:45-2:30 Transdermal Delivery of Biopharmaceuticals:
Overcoming The Barrier
Dr. Sarah Adel Ibrahim (USA)
2:30-3:00 Coffee Break
3:00-3:45 Challenges in transdermal drug delivery
Dr. Linda Felton (USA)
3:45-5:30 Clinical Evaluation of Novel Adhesive Film Containing
Ketorolac
Prof. Dr. Ibrahim Al Sarra (KSA)
February 8, 2012
8:30-9:15 Nanomedicine: Opportunities and Challenges
Prof. Dr. Uday Kompella (USA)
9:15-10:00 Manufacturing of Nanoparticles
Prof. Dr. Uday Kompella (USA)
10:00-10:30 Coffee Break
10:30-12:00 “In”s and “Out”s of Ocular Drug Delivery
Prof. Dr. Clive Wilson (GB)
12:00-1:00 Lunch
1:00-2:00 Vitreous as a barrier and vehicle for Ocular Drug
Delivery
Prof. Dr. Clive Wilson (GB)
2:00-3:00 Technology to Dose Powder for Inhalation
Eng. Fadhel Belaiba and Dr. Karlheinz Seyfang (GERMANY)
3:00-3:30 Coffee Break
3:30-4:15 Applications of Nanotechnology for Gene
Delivery
Prof. Dr. Uday Kompella (USA)
4:15-5:15 Nanotechnology for drug delivery systems
Prof. Dr. Silvia Kocova El-Arini (EGYPT)
February 9, 2012
8:30-9:15 Quality by Design (QbD): The New Paradigm
Dr. Patrick Crowley (USA)
9:15-10:00 Personalised Medicine: Opportunities and Challenges
Dr. Gino Martini (GB)
10:00-10:30 Coffee Break
10:30-11:30 Controlling Release from Dosage Forms. The Future!
Dr. Gino Martini (GB)
11:30-1:00 Breakout Session with Feedback to Consider How QbD and Science- Based Drug Design Might Be Reduced to Practice
1:00-2:00 Lunch
2:00-2:45 Factors Affecting Drug Absorption
Dr. Gino Martini (GB)
2:45-3:30 Science-Based Stability Considerations
Dr. Patrick Crowley (USA)
3:30-4:00 Coffee Break
4:00- 4:30 Drug-Excipient Interactions Dr. Patrick Crowley (USA)
4:30-5:00 Are GMP and QbD Compatible and what Needs to Change?
Discussion by Participants